GlassScriptPhysician profile
Paul Pongor
NPI 1770585705
$2,412.43
in general payments reported to CMS, 2019-2025
25 companies · $716 in 2025
The $716 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $198 · 2021: $666 · 2022: $272 · 2023: $121 · 2024: $287 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $676.41 | 2021-2025 | Triathlon, Gamma, T2 Alpha |
| Vertex Pharmaceuticals Incorporated | $263.62 | 2024-2025 | |
| Pacira Therapeutics, INC. | $190.32 | 2019-2021 | |
| Orthofix Medical, INC. | $188.41 | 2021-2025 | Physio-Stim |
| Smith+Nephew, INC. | $158.63 | 2022-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $146.94 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $125.95 | 2019-2023 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $112.33 | 2020-2025 | Iovera |
| Fidia Pharma USA INC. | $67.30 | 2019-2025 | Triluron, Hymovis |
| Terumo Bct, INC. | $53.52 | 2021 | |
| Biomarin Pharmaceutical INC. | $46.50 | 2022-2023 | Voxzogo 1.2mg |
| Sanofi-Aventis U.S. LLC | $39.67 | 2019-2020 | |
| Daiichi Sankyo INC. | $39.44 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $38.85 | 2025 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $31.43 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $29.79 | 2021 | |
| Access Pro Medical, LLC | $28.90 | 2025 | Matriderm |
| Peter Brasseler Holdings, LLC | $24.50 | 2024 | |
| Convatec INC. | $24.42 | 2025 | |
| Zimmer Biomet Holdings, INC. | $23.60 | 2021 | |
| Ethicon US, LLC | $23.40 | 2025 | Stratafix |
| Amgen INC. | $22.30 | 2023 | Evenity, Prolia |
| Polynovo North America LLC | $21.08 | 2025 | Novosorb Btm |
| Vericel Corporation | $20.16 | 2023 | Maci |
| Heraeus Medical, LLC. | $14.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pongor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.